Showing results (51-60 of 71) with videos related to
Sort By:
Pageof 8
Nature Communications|February 12, 2025
High-throughput screening identifies Aurora kinase B as a critical therapeutic target for Merkel cell carcinomaTara Gelb, Khalid A Garman, Daniel Urban, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2021
Aging and CNS Myeloid Cell Depletion Attenuate Breast Cancer Brain MetastasisAlex Man Lai Wu, Selamawit Gossa, Ramakrishna Samala, et al.Cancers|July 13, 2024
Preclinical Therapeutic Efficacy of RAF/MEK/ERK and IGF1R/AKT/mTOR Inhibition in NeuroblastomaStacey Stauffer, Jacob S Roth, Edjay R Hernandez, et al.Frontiers in Oncology|September 25, 2023
Organoids and metastatic orthotopic mouse model for mismatch repair-deficient colorectal cancerYurong Song, Travis D Kerr, Chelsea Sanders, et al.Science Translational Medicine|July 6, 2018
MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcomaMarielle E Yohe, Berkley E Gryder, Jack F Shern, et al.Molecular Cancer Therapeutics|December 4, 2025
Activity of direct KRAS(G12C) inhibitors in preclinical models of pediatric cancerHannah E Price, Stacey Stauffer, Hyun Lee, et al.Cancers|August 26, 2023
Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric RhabdomyosarcomaJerry T Wu, Adam Cheuk, Kristine Isanogle, et al.Nature Communications|July 15, 2018
Reactive astrocytic S1P3 signaling modulates the blood-tumor barrier in brain metastasesBrunilde Gril, Anurag N Paranjape, Stephan Woditschka, et al.ACS Medicinal Chemistry Letters|May 14, 2025
IRAK1/4/pan-FLT3 Kinase Inhibitors with Reduced hERG Block as Treatments for Acute Myeloid LeukemiaScott B Hoyt, Chris J Finocchio, Elizabeth Croll, et al.Journal of Experimental & Clinical Cancer Research : CR|April 24, 2023
High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinomaMartin Lang, Laura S Schmidt, Kelli M Wilson, et al.Pageof 8